As of November 2024, AIM ImmunoTech has a market cap of $15.14M. This makes AIM ImmunoTech the world's 31275th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $19.54M | -9.09% |
2023 | $21.49M | 41.94% |
2022 | $15.14M | -66.30% |
2021 | $44.93M | -48.60% |
2020 | $87.43M | 231.48% |
2019 | $26.37M | -93.18% |
2018 | $386.83M | -48.57% |
2017 | $752.16M | -49.28% |
2016 | $1.48B | -28.13% |
2015 | $2.06B | -68.00% |
2014 | $6.45B | -7.41% |
2013 | $6.96B | 8.00% |
2012 | $6.45B | 25.00% |
2011 | $5.16B | -59.18% |
2010 | $12.64B | -12.50% |
2009 | $14.44B | 55.56% |
2008 | $9.28B | -52.63% |
2007 | $19.60B | -65.45% |
2006 | $56.73B | 1.38% |
2005 | $55.96B | 14.21% |
2004 | $49.00B | -15.93% |
2003 | $58.28B | 6.10% |
2002 | $54.93B | -52.67% |
2001 | $116.05B | -5.26% |
2000 | $122.49B | -52.20% |
1999 | $256.27B | 44.55% |
1998 | $177.30B | 69.23% |
1997 | $104.77B | 80.56% |
1996 | $58.02B | - |